Sectors
NRXP
NRx Pharmaceuticals, Inc.
3.46
2 x 3.20
2 x 4.54
bid
ask
-
0.09
2.68%
10:30 AM
timesize
| Ytd | 27.49% | |
| 1y | 48.92% |
3.43
day range
3.54
1.62
52 week range
5.05
| Open | 3.52 | Prev Close | 3.55 | Low | 3.43 | High | 3.54 | Mkt Cap | 149.37M |
| Vol | 145.70K | Avg Vol | 1.14M | EPS | -0.51 | P/E | N/A | Forward P/E | -1.12 |
| Beta | 2.18 | Short Ratio | 4.80 | Inst. Own | 6.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 3.71 | 200-d Avg | 2.82 | 1yr Est | 31.67 |
| Income Statement | |||
| Total Revenue | 1.10M | ||
| Revenues (USD) | 1.10M | ||
| Cost of Revenue | 675.00K | ||
| Gross Profit | 426.00K | ||
| Operating Expenses | 6.93M | ||
| Research and Development Expense | 2.12M | ||
| Selling, General and Administrative Expense | 4.75M | ||
| Operating Income | -6.50M | ||
| Interest Expense | 240.00K | ||
| Net Income | -16.52M | ||
| Net Income Common Stock | -16.52M | ||
| Net Income Common Stock (USD) | -16.52M | ||
| Consolidated Income | -16.52M | ||
| Earnings per Basic Share | -0.44 | ||
| Earnings per Basic Share (USD) | -0.44 | ||
| Earnings per Diluted Share | -0.44 | ||
| Earning Before Interest & Taxes (EBIT) | -16.28M | ||
| Earning Before Interest & Taxes (USD) | -16.28M | ||
| Weighted Average Shares | 37.65M | ||
| Weighted Average Shares Diluted | 37.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.69M | ||
| Cash and Equivalents (USD) | 26.69M | ||
| Investments | 402.00K | ||
| Investments Non-Current | 402.00K | ||
| Trade and Non-Trade Receivables | 206.00K | ||
| Current Assets | 29.16M | ||
| Property, Plant & Equipment Net | 1.75M | ||
| Total Assets | 34.16M | ||
| Debt Current | 790.00K | ||
| Total Debt | 1.25M | ||
| Current Liabilities | 33.87M | ||
| Debt Non-Current | 456.00K | ||
| Total Liabilities | 34.33M | ||
| Accumulated Retained Earnings (Deficit) | -324.85M | ||
| Shareholders Equity | -170.00K | ||
| Shareholders Equity (USD) | -170.00K | ||
| Assets Non-Current | 5.00M | ||
| Total Debt (USD) | 1.25M | ||
| Goodwill and Intangible Assets | 2.63M | ||
| Liabilities Non-Current | 456.00K | ||
| Trade and Non-Trade Payables | 3.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 173.00K | ||
| Net Cash Flow from Financing | 29.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 19.97M | ||
| Capital Expenditure | -897.00K | ||
| Issuance (Purchase) of Equity Shares | 29.12M | ||
| Issuance (Repayment) of Debt Securities | 412.00K | ||
| Net Cash Flow from Investing | -684.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 213.00K | ||
| Net Cash Flow from Operations | -8.87M | ||
| Share Based Compensation | 139.00K | ||